天津中医药大学第一附属医院
纸质出版:2015
移动端阅览
[1]李亚平,马融,胡思源,魏小维,张喜莲,钟成梁,唐温,徐强,张美菁.小儿智力糖浆治疗儿童注意缺陷多动障碍36例临床研究[J].中医杂志,2015,56(20):1750-1754.
LI Yaping, MA Rong, HU Siyuan, et al. Clinical Study on Xiaoer Zhili Syrup(小儿智力糖浆) in the Treatment of 36 Children with Attention Deficit Hyperactivity Disorder[J]. Journal of Traditional Chinese Medicine2015, 56(20): 1750-1754.
[1]李亚平,马融,胡思源,魏小维,张喜莲,钟成梁,唐温,徐强,张美菁.小儿智力糖浆治疗儿童注意缺陷多动障碍36例临床研究[J].中医杂志,2015,56(20):1750-1754. DOI: 10.13288/j.11-2166/r.2015.20.011.
LI Yaping, MA Rong, HU Siyuan, et al. Clinical Study on Xiaoer Zhili Syrup(小儿智力糖浆) in the Treatment of 36 Children with Attention Deficit Hyperactivity Disorder[J]. Journal of Traditional Chinese Medicine2015, 56(20): 1750-1754. DOI: 10.13288/j.11-2166/r.2015.20.011.
目的观察小儿智力糖浆治疗儿童注意缺陷多动障碍(ADHD)的疗效及其特点。方法将ADHD首诊患儿72例随机分为治疗组与对照组各36例
分别给予小儿智力糖浆与静灵口服液治疗
疗程8周。治疗前后分别观察两组4
6
岁年龄层及7
1
4岁年龄层患儿ADHD症状指标[包括范德比尔特评定量表父母随访问卷(VADPRS)核心症状下降值及总分下降值、儿童总体评价量表(CGAS)复常率]及脑功能相关指标(韦氏智商量表言语智商与操作智商差值、神经软体征阳性率、脑电地形图异常率)的变化。结果两组不同年龄层患儿VADPRS量表总分下降值均随治疗时间延长持续提高
两组比较差异无统计学意义(P
>
0.05)。治疗8周后
治疗组4
6
岁患儿核心症状多动冲动改善优于对照组(P
<
0.05)。治疗6、8周后
治疗组4
6
岁患儿CGAS复常率分别为52.63%、94.74%
对照组为44.44%、72.22%;治疗组7
1
6岁患儿CGAS复常率为47.06%、64.71%
对照组为50.00%、77.78%
两组比较差异均无统计学意义(P
>
0.05)
但两组4
6
岁年龄层患儿均显示更高的复常率。两组不同年龄层患儿治疗后4、6、8周指鼻试验、翻手试验、轮替试验阳性率及言语智商与操作智商差值比较
差异均无统计学意义(P
>
0.05)。结论小儿智力糖浆较静灵口服液对4
6
岁ADHD儿童的多动冲动症状改善更显著
且有对4
6
岁ADHD患儿症状及脑功能改善优于7
1
4岁患儿的趋势。
Objective To observe the effect and characteristics of Xiaoer Zhili Syrup in the treatment of children with attention deficit hyperactivity disorder( ADHD). Methods Swenty-two cases of first diagnosed ADHD accorded with inclusion criteria were randomly divided into treatment group and control group
with 36 cases in each group.The treatment group was given Xiaoer Zhili Syrup
and the control group was given Jingling Oral Liquid( 静灵口服液). The treatment course was 8 weeks for both groups. Before and after treatment
the changes of ADHD symptom indices [including core symptoms decreased value and total score decreased value of Vanderbilt rating scale parents follow-up questionnaires( VADPRS) and the normalization rate of the overall evaluation scale for children( CGAs) ]and the brain function related indices( differences between verbal IQ and performance IQ in Wechsler Intelligence Scale
the positive rate of neurological soft signs
and EEG abnormal rate) were observed in children aged 4 to 6years old and 7 to 14 years old respectively in two groups. Results The total scores of VADPRS in two groups were significantly decreased as the treatment time went on
and there was no significant difference between the two groups( P > 0. 05). After 8 weeks of treatment
the improvement of the core symptoms of 4 to 6 years old children in the treatment group( hyperactivity and impulsion) was better than that in the control group( P < 0. 05). After treatment for 6 and 8 weeks
the normalization rate of CGAS of 4 to 6 years old children were 52. 63% and 94. 74% respectively in the treatment group
and 44. 44% and 72. 22% respectively in the control group;
the normalization rate of CGAS of age 7 to 16 years old were 47. 06% and 64. 71% in the treatment group
and 50. 00% and 77. 78% in the control group
with no statistically significant differences between groups( P > 0. 05). However in both groups
children aged4 to 6 years old showed a higher normalization rate. After treatment for 4
6
and 8 weeks
there were no statistically significant differences in the positive rates of finger-to-nose test
double hand test
and alternating movement test
as well as the difference of verbal IQ and performance IQ between children with different age levels in two groups( P >0. 05). Conclusion Xiaoer Zhili Syrup can significantly improve the hyperactivity and impulsive symptoms in ADHD children aged of 4 to 6 years old than Jingling Oral Liquid
and there is a trend of better improvement in symptoms and brain function in children aged of 4 to 6 years old than those of 7 to 14 years old.
0
浏览量
411
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号